ENTITY
Beijing Tong Ren Tang Chinese Medicine

Beijing Tong Ren Tang Chinese Medicine (3613 HK)

34
Analysis
Health Care • Hong Kong
Beijing Tong Ren Tang Chinese Medicine Co., Ltd. is primarily involved in the manufacturing, retail, and wholesale of traditional Chinese medicine products and healthcare products, alongside offering Chinese medical consultation and treatment services. Key products include Angong Niuhuang Pill and Sporoderm broken Ganoderma Lucidum Spores Powder Capsules. The company is headquartered in Hong Kong and was established in 2004 as the overseas development platform for the renowned Tong Ren Tang brand, which originated in 1669.
more
bullish•Lung Fung Group
•21 Jul 2026 08:59

Lung Fung Group (2290 HK): Still Looks Undervalued

Lung Fung announced that its retail sales revenue increased 21.2% in 1Q FY27, while same-store sales grew 10.3%. This is solid momentum, suggesting...

Logo
169 Views
Share
•08 Aug 2026 12:42

Primer: Beijing Tong Ren Tang Chinese Medicine (3613 HK) - Aug 2026

Esteemed Brand with Deep Heritage: Beijing Tong Ren Tang Chinese Medicine leverages its centuries-old brand, established in 1669 and once the...

Logo
99 Views
Share
bullish•Lung Fung Group
•29 May 2026 08:00

Lung Fung Group (2290 HK) IPO: Too Cheap to Ignore

​Lung Fung Group seeks to raise HK$672m in IPO, showing higher margins and profit compared to Sa Sa, with potential 29% upside at IPO price range.

Logo
255 Views
Share
•27 Sep 2026 10:05

HK Connect Flows Weekly (Sep 24th): Knowledge Atlas, Bidu, AIA, Chinagoldintl, Hua Hong Semi, CNOOC

We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for Knowledge Atlas, Bidu, AIA, Chinagoldintl, Hua Hong Semi,...

Logo
106 Views
Share
•06 Aug 2026 20:11

HSCI / HK Connect Sep 2026 Inclusion Forecast and Positioning

We expect 36 southbound Connect ADDs, 31 new and 5 returning, and 25 DELETEs from the current Connect list at the HSCI September review, effective...

Logo
162 Views
Share
x